Generex Biotechnology Corporation Receives Positive Responses From Independent Physicians and Nurse Practitioners in Recent Focus Groups Conducted in the United States for Generex Oral-lyn(TM)

WORCESTER, Mass., March 11, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that Health Management Resources, Inc. (HMR) has recently conducted two focus groups in Indianapolis for Generex Oral-lyn™. HMR provides educational programs, materials, and services to the healthcare industry. Specializing in diabetes management, HMR has collaborated with medical associations and industry to develop clinical practice guidelines and to facilitate delivery of diabetes-related information and education to healthcare providers and people with diabetes.